137 related articles for article (PubMed ID: 3190179)
1. Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.
Jorgensen JH; Redding JS; Maher LA
Antimicrob Agents Chemother; 1988 Oct; 32(10):1477-80. PubMed ID: 3190179
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of a new oral carbacephem, LY163892.
Howard AJ; Dunkin KT
J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
[TBL] [Abstract][Full Text] [Related]
3. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
Jones RN; Barry AL
J Clin Microbiol; 1988 Apr; 26(4):770-3. PubMed ID: 3259247
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of LY163892, cefaclor, and cefuroxime.
Knapp CC; Washington JA
Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
Jones RN; Barry AL
J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity and beta-lactamase stability of LY163892.
Cao C; Chin NX; Neu HC
J Antimicrob Chemother; 1988 Aug; 22(2):155-65. PubMed ID: 3263352
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and beta-lactamase stability of LY163892.
Pelosi E; Fontana R
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):549-51. PubMed ID: 3141170
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibilities of common pediatric pathogens to LY163892.
Shelton S; Nelson JD
Antimicrob Agents Chemother; 1988 Feb; 32(2):268-70. PubMed ID: 3129989
[TBL] [Abstract][Full Text] [Related]
9. Effect of refrigerated storage on cefaclor in Mueller-Hinton agar.
Surprenant AM; Preston DA
J Clin Microbiol; 1985 Jan; 21(1):133-4. PubMed ID: 3968200
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.
Silver MS; Counts GW; Zeleznik D; Turck M
Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies with cefaclor, a new oral cephalosporin.
Sanders C
Antimicrob Agents Chemother; 1977 Oct; 12(4):490-7. PubMed ID: 921244
[TBL] [Abstract][Full Text] [Related]
12. Regression curve analysis of cephalosporin activity.
Washington JA; Yu PK
Appl Microbiol; 1970 Apr; 19(4):589-93. PubMed ID: 5418940
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
Preston DA; Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
[TBL] [Abstract][Full Text] [Related]
14. Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
Jones RN; Barry AL
Eur J Clin Microbiol; 1987 Oct; 6(5):570-1. PubMed ID: 3501757
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.
Doern GV; Vautour R; Parker D; Tubert T; Torres B
Antimicrob Agents Chemother; 1991 Jul; 35(7):1504-7. PubMed ID: 1929318
[TBL] [Abstract][Full Text] [Related]
16. Effect of media and blood on the antimicrobial activity of cephalosporins on serogroup D streptococci: a review.
Thornsberry C; Sahm DF
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):75S-84S. PubMed ID: 6430633
[TBL] [Abstract][Full Text] [Related]
17. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
Dubreuil L; Derriennic M; Sedallian A
Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
[TBL] [Abstract][Full Text] [Related]
18. Summary of laboratory studies on the antibacterial activity of cefaclor.
Preston DA
Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
[TBL] [Abstract][Full Text] [Related]
19. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.
Sahm DF; Baker CN; Jones RN; Thornsberry C
J Clin Microbiol; 1984 Sep; 20(3):561-7. PubMed ID: 6436309
[TBL] [Abstract][Full Text] [Related]
20. Effect of assay medium on the antibacterial activity of certain penicillins and cephalosporins.
Pursiano TA; Misiek M; Leitner F; Price KE
Antimicrob Agents Chemother; 1973 Jan; 3(1):33-9. PubMed ID: 4790574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
